Nassim Usman, Catalyst Biosciences CEO

Af­ter $60M Ver­tex deal, group of Cat­a­lyst share­hold­ers claims biotech could’ve sold as­sets three years ago

Cat­a­lyst Bio­sciences was down to five em­ploy­ees in March, and the biotech need­ed to do some­thing af­ter two rounds of lay­offs, a nixed col­lab­o­ra­tion and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.